OTC:ZPTA
Zapata Quantum, Inc.
A pioneering OTC-traded developer of fault-tolerant quantum computing hardware and software stacks targeting enterprise clients in pharmaceuticals and logistics.
Key Metrics
Investment Thesis
Bull Case
Early investors may see value in Zapata Quantum's pioneering position in the nascent quantum computing market, where first-mover advantages could translate into dominant market share as commercial applications mature. The company's focus on fault-tolerant hardware addresses a critical gap left by competitors focusing solely on noisy intermediate-scale quantum devices, potentially capturing high-margin enterprise contracts soon. With substantial paid-in capital of $104.3M already deployed, the stock offers speculative upside if breakthroughs in qubit stability lead to rapid commercial scaling.
Bear Case
The financial data reveals a company burning through its limited cash reserves with no clear path to profitability, highlighted by a massive $38.1M loss and an operating deficit that dwarfs its revenue of just $3.9M. The retained earnings deficit of -$127.7M suggests deep structural issues where current operations consistently destroy value rather than create it, making the business model unsustainable at present valuations. Investors should avoid this stock due to the high risk of dilution from future equity financing needed to cover the substantial operating expenses and interest costs.
About Zapata Quantum, Inc.
Zapata Quantum Inc. operates as a quantum computing software and hardware solutions provider, serving research institutions and enterprise clients with scalable quantum processors and control systems. The company focuses on advancing error-corrected qubits and cloud-based quantum platforms to accelerate drug discovery, materials science, and optimization problems in high-value sectors.
Analysis
Management Discussion
Zapata Quantum continues to prioritize long-term R&D investments, evidenced by $4.4M in research and development spending, while attempting to expand its commercial footprint through significant marketing expenditures of $7.1M. However, the financial position has deteriorated sharply with a net loss of $38.1M in 2024 compared to a profit of $1.9M in 2022, leaving the company with only $359k in ending cash and a substantial debt burden relative to its current assets. This aggressive spending strategy has failed to generate sufficient revenue growth, resulting in a negative operating profit of -$23.0M and raising concerns about sustainability without immediate capital injections.
Industry Overview
The global quantum computing industry is in a hyper-competitive race between hardware manufacturers and software providers to achieve fault tolerance, with early entrants facing high capital requirements and technical hurdles. While traditional superconducting qubit leaders face challenges in scaling error correction, specialized firms aiming for niche applications in chemistry and optimization offer differentiated value propositions that could disrupt the status quo. Success in this sector depends heavily on securing large-scale government or corporate contracts before liquidity constraints force smaller players out of the market.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $3.9M |
| Cost of Revenue | $0 | $0 | $3.2M |
| Gross Profit | $0 | $0 | $635.0K |
| Operating Expenses | $1.5M | $8.3M | $23.7M |
| Operating Income | $-1.5M | $-8.3M | $-23.0M |
| R&D | — | — | $4.4M |
| G&A | — | — | $12.1M |
| Marketing | — | — | $7.1M |
| Stock-Based Comp | — | — | $561.0K |
| D&A | — | — | $118.0K |
| Other OpEx | — | — | $0 |
| Non-Operating Income | $0 | $0 | $-15.1M |
| Interest Expense | — | $70.9K | $962.0K |
| Interest Income | $3.4M | $8.2M | — |
| Pre-Tax Income | $-1.5M | $-8.3M | $-38.1M |
| Income Tax | $0 | $0 | $20.0K |
| Continuing Ops | $-1.5M | $-8.3M | $-38.1M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $1.9M | $-862.9K | $-38.1M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $1.9M | $-862.9K | $-38.1M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $1.2M | $205.5K | $2.2M |
| Cash & Equivalents | $0 | $0 | $38.0K |
| Accounts Receivable | — | — | $1.6M |
| Prepaid Expenses | $590.9K | $44.3K | $229.0K |
| Other Current Assets | $616.1K | $161.2K | $349.0K |
| Long-Term Assets | $239.2M | $86.3M | $550.0K |
| Total Assets | $240.4M | $86.5M | $2.7M |
| Current Liabilities | $115.3K | $955.8K | $23.7M |
| Accounts Payable | — | — | $14.0M |
| Deferred Revenue | — | — | $406.0K |
| Other Current Liab | $85.0K | — | $9.3M |
| Long-Term Liabilities | $8.2M | $14.5M | $2.5M |
| Total Liabilities | $8.3M | $15.5M | $26.2M |
| Shareholders' Equity | $232.1M | $71.0M | $-23.5M |
| Paid-In Capital | $0 | $0 | $104.3M |
| Retained Earnings | $-7.1M | $-15.3M | $-127.7M |
| AOCI | — | — | $-109.0K |
| Total L&E | $240.4M | $86.5M | $2.7M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $1.9M | $-862.9K | $-38.1M |
| Non-Cash Adjustments | $-4.4M | $-2.6M | $12.6M |
| Working Capital Changes | $619.2K | $378.9K | $7.4M |
| Cash from Operations | $-1.9M | $-3.0M | $-18.1M |
| Capital Expenditures | — | — | $34.0K |
| Cash from Investing | $-235.8M | $161.0M | $-34.0K |
| Share Buybacks | — | $161.0M | — |
| Cash from Financing | $238.3M | $-158.5M | $15.1M |
| FX Effect | $0 | $0 | $-63.0K |
| Net Change in Cash | $616.1K | $-454.9K | $-3.1M |
| Beginning Cash | $0 | $616.1K | $3.5M |
| Ending Cash | $616.1K | $161.2K | $359.0K |
Frequently Asked Questions
How does Zapata Quantum, Inc. make money?
1) Quantum Hardware Development: Manufacturing of superconducting qubit chips and cryogenic control electronics. 2) Quantum Software & Cloud Services: Access to quantum processors via cloud APIs for algorithm development and simulation. 3) Strategic Partnerships & Licensing: Revenue streams from collaborations with academic institutions and pharmaceutical firms for specialized quantum chemistry simulations.
What are the main risks for ZPTA?
1) Extreme Loss Trajectory: The company reported a massive $38.1M net loss in 2024, exacerbating an already significant retained earnings deficit of $127.7M and threatening liquidity given low cash reserves. 2) High Burn Rate vs. Low Revenue: Operating expenses exceeded revenue by over $19M, with marketing spending alone at $7.1M, indicating potential inefficiency in scaling commercial adoption. 3) OTC Market Liquidity & Volatility: Trading on the OTC market exposes investors to low liquidity, wide bid-ask spreads, and limited analyst coverage, making exit strategies difficult during downturns.
What is ZPTA's competitive advantage?
1) Proprietary Qubit Architecture: Unique approach to extending coherence times and error rates below fault-tolerance thresholds, offering superior performance compared to standard industry benchmarks. 2) Integrated Control Stack: Proprietary firmware that simplifies the integration of quantum processors into existing enterprise IT infrastructures, reducing time-to-value for clients. 3) Niche Market Focus: Deep specialization in complex optimization problems for drug discovery, creating high barriers to entry for generalist competitors.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.